Specific multi-strain formulations also exhibit promise in both preventing the initial onset of pouchitis and in maintaining remission following its successful induction
Key considerations include: Rybelsus is not a hormonal contraceptive and does not directly alter oestrogen or progesterone levels Any menstrual changes are likely secondary to metabolic improvements rather than a direct drug effect Individual responses vary considerably, and not all women will experience cycle alterations Other common causes of menstrual changes (pregnancy, perimenopause, gynaecological conditions) should be considered first If you notice changes to your menstrual cycle after starting Rybelsus, it is important to discuss these with your GP or diabetes specialist nurse
More data is needed to understand potential side effects and their lasting impact on weight and metabolic health
Absorbance was measured at 412 nm in a plate reader (CLARIOstar Plus Microplate, BMG LabTech) using kinetic mode with measurements every 45 s for 45 min at 37 C
Wilkinson, Francesco Zaccardi, Thomas Yates, Melanie J
Mishra, Director of the NCCS, for the same